Xenex Healthcare Services

Xenex Healthcare Services

Maker of LightStrike UV disinfection robots; FDA De Novo-authorized; deployed in 400+ hospitals including Mayo Clinic and MD Anderson.

Visit Website

Company Overview

Xenex Healthcare Services is a US medical robotics company headquartered in San Antonio, Texas, that manufactures the LightStrike family of pulsed xenon UV disinfection robots for healthcare facilities. The LightStrike and LightStrike+ robots, the latter being FDA De Novo authorized as the first and only UV microbial reduction robot cleared for healthcare use, are deployed in over 400 hospitals, Veterans Affairs facilities, and Department of Defense installations globally, including Mayo Clinic, MD Anderson Cancer Center, and Stanford Health Care. The company is backed by EW Healthcare Partners, Battery Ventures, Piper Sandler, Malin Corporation, and Tectonic Ventures.

Capabilities & Activities

Primary type & automation activities this supplier delivers:

Applications & Industries

Product Categories

Products & Solutions

LightStrike+ UV Robot

FDA De Novo-authorized pulsed xenon UV disinfection robot for healthcare facilities; the first and only UV device in its FDA product classification for microbial reduction.

LightStrike6 UV Robot

Latest generation UV disinfection robot from Xenex; received Health Canada registration making it the first and only UVC technology authorized for healthcare use across North America.

Partnership & Notable clients

Associating Events

Listed in RobotToday Supplier Discovery. Verified Profile

More related news

  1. 1
  2. 2
  3. 3
  4. 4
    Suzy Teele’s Mission at ARM Institute RobotToday  · Oct 13, 2026

Contact Xenex Healthcare Services

WEBSITE

https://xenex.com

EMAIL

[email protected]

PHONE

+1 800-553-0069

HEADQUARTERS

1074 Arion Circle
Suite 116
San Antonio , Texas  78216

United States

Company Facts

Founded

2009

Primary Role

Manufacturer

Company Size

employees 100-500

Primary Region

North America

Annual Sales

-

Funding Stage

Growth / Late-Stage VC

Funding Total

$ 38,000,000

Export Markets